Influence of individual CpG methylation status on outcome in adult patients with glioblastoma multiforme receiving alkylating agent treatment

Autor: Siller, S, Lauseker, M, Giese, A, Tonn, JC, Niyazi, KM, Thon, N, Suchorska, B, Kreth, FW

Publikováno v: 70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie; 20190512-20190515; Würzburg; DOCV127 /20190508/

Objective: Methylation of the O-6-methylguanine-DNA methyltransferase (MGMT) promotor causes gene silencing and has been associated with a favourable prognosis in patients with glioblastoma multiforme (GBM) receiving alkylating chemotherapy. However,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8de9f0bfa0456fb32892d6a39acb7dfd

Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy-a case report and literature review.

Autor: Hoffmann E; University Hospital for Radiotherapy, University Hospital Tübingen, 72076, Tübingen, Germany. elgin.hoffmann@med.uni-tuebingen.de., Böke S; University Hospital for Radiotherapy, University Hospital Tübingen, 72076, Tübingen, Germany., De-Colle C; University Hospital for Radiotherapy, University Hospital Tübingen, 72076, Tübingen, Germany., Lengerke C; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany., Niyazi KM; University Hospital for Radiotherapy, University Hospital Tübingen, 72076, Tübingen, Germany., Gani C; University Hospital for Radiotherapy, University Hospital Tübingen, 72076, Tübingen, Germany.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Oct; Vol. 200 (10), pp. 908-915. Date of Electronic Publication: 2024 Jan 29.